BR112012021372A2 - nanopartícula, processo para produção de nanopartículas, composição e gênero alimentício - Google Patents

nanopartícula, processo para produção de nanopartículas, composição e gênero alimentício

Info

Publication number
BR112012021372A2
BR112012021372A2 BR112012021372A BR112012021372A BR112012021372A2 BR 112012021372 A2 BR112012021372 A2 BR 112012021372A2 BR 112012021372 A BR112012021372 A BR 112012021372A BR 112012021372 A BR112012021372 A BR 112012021372A BR 112012021372 A2 BR112012021372 A2 BR 112012021372A2
Authority
BR
Brazil
Prior art keywords
nanoparticle
foodstuff
composition
production
nanoparticles
Prior art date
Application number
BR112012021372A
Other languages
English (en)
Other versions
BR112012021372B8 (pt
BR112012021372B1 (pt
Inventor
Irene Esparza Catalán
Ana Romo Hualde
Carolina González Ferrero
Carlos Javier Gonzalez Navarro
Juan Manuel Irache Garreta
Maite Agueros Bazo
Original Assignee
Ct Nac De Tecnologia Y Seguridad Alimentaria Lab Del Ebro
Univ Navarra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Nac De Tecnologia Y Seguridad Alimentaria Lab Del Ebro, Univ Navarra filed Critical Ct Nac De Tecnologia Y Seguridad Alimentaria Lab Del Ebro
Publication of BR112012021372A2 publication Critical patent/BR112012021372A2/pt
Publication of BR112012021372B1 publication Critical patent/BR112012021372B1/pt
Publication of BR112012021372B8 publication Critical patent/BR112012021372B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

nanopartícula, processo para produção de nanopartículas, composição e gênero alimentício. a presente invenção refere-se a nanopartículas para encapsular compsotos, sua preparação e usos, compreendendo uma matriz de caseína, um aminoácido básico e um metal selecionado dentre um metal divalente, um metal trivalente e suas combinações. as referidas nanopartículas podem encapsular um compsoto biologicamene ativo hidrossolúvel ou lipossolúvel. a invenção é aplicável nos setores alimentício, farmacêutico e cosmético e no setor de nanotecnologia.
BR112012021372A 2010-02-26 2011-02-24 processo para produção de nanopartículas, nanopartícula produzida pelo referido processo, composição e gênero alimentício BR112012021372B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP201030286 2010-02-26
ES201030286 2010-02-26
PCT/ES2011/070118 WO2011104410A1 (es) 2010-02-26 2011-02-24 Nanopartículas para encapsulación de compuestos, su preparación y usos

Publications (3)

Publication Number Publication Date
BR112012021372A2 true BR112012021372A2 (pt) 2016-08-09
BR112012021372B1 BR112012021372B1 (pt) 2021-04-06
BR112012021372B8 BR112012021372B8 (pt) 2021-05-25

Family

ID=44263006

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012021372A BR112012021372B8 (pt) 2010-02-26 2011-02-24 processo para produção de nanopartículas, nanopartícula produzida pelo referido processo, composição e gênero alimentício

Country Status (14)

Country Link
US (1) US10894006B2 (pt)
EP (1) EP2540169B1 (pt)
JP (1) JP5758919B2 (pt)
KR (1) KR101782547B1 (pt)
AU (1) AU2011219694B2 (pt)
BR (1) BR112012021372B8 (pt)
CA (1) CA2789518C (pt)
DK (1) DK2540169T3 (pt)
ES (1) ES2594929T3 (pt)
MX (1) MX342700B (pt)
PL (1) PL2540169T3 (pt)
PT (1) PT2540169T (pt)
RU (1) RU2552957C2 (pt)
WO (1) WO2011104410A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6235779B2 (ja) * 2012-03-28 2017-11-22 株式会社コーセー 葉酸含有組成物及び葉酸の安定化方法
EP2968070B1 (en) 2013-03-15 2019-12-18 Glanbia Nutritionals (Ireland) Ltd. Method for improving bioavailability of therapeutic compounds
EP2856987A1 (en) 2013-10-07 2015-04-08 Absorbest AB A wound dressing and a method for manufacturing a wound dressing
KR101652459B1 (ko) * 2015-11-30 2016-09-02 진효준 우주에서 음식물 가열 및 섭취하기 위한 장치
RU2626529C1 (ru) * 2016-02-10 2017-07-28 Александр Александрович Кролевец Способ получения йогурта, обогащенного витамином Е
RU2644228C2 (ru) * 2016-03-18 2018-02-08 Александр Александрович Кролевец Способ получения кефира, обогащенного витамином D
RU2645462C2 (ru) * 2016-04-22 2018-02-21 Александр Александрович Кролевец Способ получения творога с наноструктурированным витамином D
EP3727402A1 (en) 2017-12-19 2020-10-28 Nanobiotix Nanoparticles for use in enhancing brain performances or in treating stress
KR20200110321A (ko) 2017-12-19 2020-09-23 나노비오띡스 신경 장애의 치료에서 사용하기 위한 나노입자
RU2688770C1 (ru) * 2018-12-11 2019-05-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Способ приготовления белоксодержащего десертного желейного продукта
RU2703798C1 (ru) * 2019-05-07 2019-10-22 Александр Александрович Кролевец Способ производства мороженого с наноструктурированной фолиевой кислотой
IN202041023813A (pt) * 2020-06-06 2020-08-07
IT202000030992A1 (it) * 2020-12-16 2022-06-16 Tech Scientific S R L Sistema per il rilascio controllato di principi attivi
WO2024100217A1 (fr) * 2022-11-10 2024-05-16 Université De Lorraine Nanoclusters à base de zinc, leurs procédés d'obtention et leurs utilisations pour lutter contre les carences en zinc

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146649A (en) * 1976-10-14 1979-03-27 Faberge, Incorporated Skin moisturizing composition containing a polyethoxy fatty alcohol and a polyethoxy glycoside
IE55320B1 (en) 1983-06-16 1990-08-01 Farley Health Products Infant foods
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
CA2329005C (en) 1998-04-17 2006-01-03 Ortho-Mcneil Pharmaceutical, Inc. Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
DE19820302A1 (de) * 1998-05-04 2000-02-24 Basf Ag Kern/Schale-Partikel, ihre Herstellung und Verwendung
JP3503884B2 (ja) * 2000-01-28 2004-03-08 花王株式会社 化粧料
JP2002068922A (ja) * 2000-08-23 2002-03-08 Nonogawa Shoji Kk 液状乳化化粧料
DE10042833A1 (de) * 2000-08-30 2002-03-14 Basf Ag Feste Zubereitungen mit einer Multi-Kern Struktur
US7105176B2 (en) * 2000-11-29 2006-09-12 Basf Aktiengesellschaft Production of solid preparations of water-soluble, sparingly water-soluble or water-insoluble active compounds
RU2213493C2 (ru) 2001-05-29 2003-10-10 Устинова Александра Васильевна Консервы на мясной основе для питания беременных и кормящих женщин
RU2223672C2 (ru) 2002-03-22 2004-02-20 Государственное учреждение Всероссийский научно-исследовательский институт птицеперерабатывающей промышленности Консервы из мяса птицы для питания женщин в период беременности
KR20040053740A (ko) * 2003-06-23 2004-06-24 (주)오이넷 지하철용 광고 시스템 및 그 제어방법
ES2587016T5 (es) * 2004-08-19 2020-02-27 Dsm Ip Assets Bv Nuevas composiciones de sustancias liposolubles
JP2006115751A (ja) * 2004-10-21 2006-05-11 Kyushu Univ 疎水性物質を吸着保持したナノサイズのタンパクミセル構造体の製造方法
JP2006182891A (ja) * 2004-12-27 2006-07-13 Nippon Shokuhin Kako Co Ltd 単孔担持体澱粉およびその製造法
ES2302571B2 (es) 2005-03-18 2009-03-16 Universidad Complutense De Madrid Procedimiento de obtencion de embutidos cocidos enriquecidos con acido folico.
ATE472317T1 (de) * 2006-03-27 2010-07-15 Nestec Sa Kosmetische verwendung von molkeproteinmizellen
EP2011472A4 (en) 2006-03-29 2013-01-23 Fujifilm Corp CASEIN-NANOPARTICLES
US20100233219A1 (en) * 2006-03-30 2010-09-16 Fujifilm Corporation Inorganic nanoparticle compromising an active substance immobilized on the surface and a polymer
WO2007122613A1 (en) * 2006-04-20 2007-11-01 Technion Research And Development Foundation Ltd. Casein micelles for nanoencapsulation of hydrophobic compounds
DE102006061929A1 (de) * 2006-12-20 2008-06-26 Takata-Petri Ag Optischer Lenkwinkelsensor zur Bestimmung des Absolutwertes des Lenkwinkels
EP1941804A1 (de) 2007-01-08 2008-07-09 Rivella International AG Getränk auf der Basis von Milchserum, Grüntee-Extrakt und nahrungsergänzenden Zusatzstoffen
JP2008189784A (ja) * 2007-02-02 2008-08-21 Kyushu Univ 刺激応答性タンパク質ナノ粒子
JP2009040722A (ja) 2007-08-09 2009-02-26 Fujifilm Corp 複数のタンパク質からなるカゼインナノ粒子
US8865222B2 (en) * 2008-02-11 2014-10-21 Technion Research And Development Foundation Ltd. Beta-casein assemblies for enrichment of food and beverages and methods of preparation thereof
DE102008036576A1 (de) * 2008-07-31 2010-02-04 Gelita Ag Partikel aus Kollagenmaterial und Verfahren zur Herstellung
JP2010132609A (ja) * 2008-12-05 2010-06-17 Fujifilm Corp カゼインナノ粒子

Also Published As

Publication number Publication date
PT2540169T (pt) 2016-10-11
KR20130045849A (ko) 2013-05-06
US10894006B2 (en) 2021-01-19
WO2011104410A1 (es) 2011-09-01
EP2540169A1 (en) 2013-01-02
JP5758919B2 (ja) 2015-08-05
CN102869271A (zh) 2013-01-09
CA2789518C (en) 2018-09-11
AU2011219694B2 (en) 2014-12-18
US20130209530A1 (en) 2013-08-15
DK2540169T3 (en) 2016-10-03
JP2013520191A (ja) 2013-06-06
AU2011219694A1 (en) 2012-09-27
EP2540169B1 (en) 2016-07-06
RU2012141088A (ru) 2014-04-27
PL2540169T3 (pl) 2016-12-30
BR112012021372B8 (pt) 2021-05-25
RU2552957C2 (ru) 2015-06-10
BR112012021372B1 (pt) 2021-04-06
MX342700B (es) 2016-10-10
CA2789518A1 (en) 2011-09-01
ES2594929T3 (es) 2016-12-23
KR101782547B1 (ko) 2017-09-27
MX2012009863A (es) 2013-01-29

Similar Documents

Publication Publication Date Title
BR112012021372A2 (pt) nanopartícula, processo para produção de nanopartículas, composição e gênero alimentício
BR112013000675A2 (pt) nanopartícula, processo para produzir uma nanopartícula compreendendo uma matriz de zeína e um aminoácido básico, processo para produzir uma nanopartícula compreendendo uma matriz de zeína, e um aminoácido básico e um composto biologicamente ativo solúvel em gordura, composição e produto alimentar
BR112015000041A2 (pt) micropartícula, método para a obtenção das micropartículas definidas, composição, produto alimentar, farmacêutico, cosmecêutico ou nutracêutico e uso de uma micropartícula
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
WO2012104275A3 (en) Nanoparticles delivery systems, preparation and uses thereof
WO2013066835A3 (en) Compounds and methods
WO2013066839A3 (en) Compounds and methods
CA2865594C (en) Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
BR112014028841A2 (pt) processo para preparação de n-[5-(3,5-difluoro-benzil)-1h-indazol-3-il]-4-(4-metil-piperazin-l-il)-2-(tetra-hidro-piran-4-ilamino)-benzamida
WO2012121528A3 (en) Magnetic nanocomposite specific for thyroid cancer and use thereof
BR112015012547A2 (pt) composições de prostaciclina e métodos de sua utilização
MX2010005542A (es) Producto para el cuidado oral y metodos de uso y fabricacion del mismo.
BR112014002757A2 (pt) encapsulados
EP2826771A3 (en) Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
EP3228311A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
WO2011027258A3 (en) Scented capsules
BR112014008744A2 (pt) preparação de libertação prolongada, e, métodos para produzir uma preparação de liberação prolongada, e para prevenir e/ou retardar o início ou suprimir a progressão da doença de alzheimer
WO2010111257A3 (en) Targeted schiff base complexes
BR112012020223A2 (pt) "pélete farmacêutica de fator de crescimento epidérmico administrável por via oral"
WO2014006571A3 (en) Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof
BR112015012824A2 (pt) composições e métodos para tratar cáries dentárias
WO2011114071A3 (fr) Cyclopeptide synthetique, procede de preparation et utilisations
MX2017007018A (es) Nanopartículas para encapsular compuestos, su preparación y sus usos.
BR112013006307A2 (pt) fenilacetamidas e fenilpropanamidas substituídas e o seu uso

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: UNIVERSIDAD DE NAVARRA (ES) , CENTRO NACIONAL DE T

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/11 (2006.01), A23L 33/10 (2016.01), A23L 33

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/02/2011 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF